Northwest Biotherapeutics announced that its CTO, Dr. Marnix Bosch, will deliver a keynote at the UK NHS CancerCare Oncology Conference discussing personalized dendritic cell-based cancer vaccines like DCVax®. The presentation will cover new cancer vaccine developments, clinical trial results, and potential combination therapies. The company is advancing DCVax®-L for glioblastoma, with a Phase III trial completed and regulatory review underway in the UK, and DCVax®-Direct for inoperable solid tumors progressing to Phase II trials. This highlights Northwest Biotherapeutics' focus on innovative, less toxic cancer immunotherapies with potential commercial approval on the horizon.
Northwest Biotherapeutics' recent oncology conference keynote comes amid a health sector where 69 of 100 US stocks rose today on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 06, 2026 12:11 WIB: ADMA Biologics Inc (ADMA) traded at USD 10.10 with a typical hold time of 17 days and 100% sell order activity; Bristol-Myers Squibb Co (BMY) was at USD 58.81 with a 92-day hold time and 93% buy order activity; Intuitive Surgical, Inc. (ISRG) stood at USD 406.80 with an 84-day hold time and 54% sell order activity.
Elon Musk has confirmed that his company is in discussions with Terafab, marking a potential new chip manufacturing partner alongside Intel, which has been the only named chip partner until now. This development could diversify the supply chain and e...
Bitcoin's recent price movements align with a historical cycle pattern suggesting it may have reached a low point, potentially signaling the start of a new bull market. Analysts project Bitcoin could hit $190,000 soon, with some traders like Peter Br...
Bitcoin (BTC) traded close to $85,580 as buying interest surpassed selling on Binance perpetual and Hyperliquid perpetual markets. Binance perpetual had $49.7 million in buy orders versus $45.7 million in sell orders, showing a $4 million net buying ...
Americas Gold and Silver (USAS) has taken full ownership of the high-grade Galena silver mine and acquired the Crescent mine to increase future production. Despite a weak second quarter at Galena, management targets 3.2–3.6 million ounces of silver o...
BTW surged 23.7% to $1.20, leading altcoin gains while Bitcoin remained stable around $85,583. This sharp rise highlights growing investor interest in specific altcoins despite a 3.3% drop in total crypto market cap and steady Bitcoin dominance at 59...
